- Home
- IPHA vs FCCO Comparison
IPHA vs FCCO Comparison
Compare IPHA & FCCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPHA
- FCCO
- Stock Information
- Founded
- IPHA 1999
- FCCO 1994
- Country
- IPHA France
- FCCO United States
- Employees
- IPHA N/A
- FCCO N/A
- Industry
- IPHA Biotechnology: Pharmaceutical Preparations
- FCCO Major Banks
- Sector
- IPHA Health Care
- FCCO Finance
- Exchange
- IPHA Nasdaq
- FCCO Nasdaq
- Market Cap
- IPHA 160.1M
- FCCO 182.4M
- IPO Year
- IPHA 2019
- FCCO 1998
- Fundamental
- Price
- IPHA $1.83
- FCCO $24.86
- Analyst Decision
- IPHA Strong Buy
- FCCO Strong Buy
- Analyst Count
- IPHA 1
- FCCO 2
- Target Price
- IPHA $11.00
- FCCO $30.00
- AVG Volume (30 Days)
- IPHA 11.9K
- FCCO 77.0K
- Earning Date
- IPHA 03-27-2025
- FCCO 07-23-2025
- Dividend Yield
- IPHA N/A
- FCCO 2.40%
- EPS Growth
- IPHA N/A
- FCCO 37.48
- EPS
- IPHA N/A
- FCCO 1.98
- Revenue
- IPHA $20,831,349.00
- FCCO $67,933,000.00
- Revenue This Year
- IPHA $209.83
- FCCO $18.61
- Revenue Next Year
- IPHA $83.15
- FCCO $11.88
- P/E Ratio
- IPHA N/A
- FCCO $12.65
- Revenue Growth
- IPHA N/A
- FCCO 16.46
- 52 Week Low
- IPHA $1.29
- FCCO $16.06
- 52 Week High
- IPHA $3.51
- FCCO $27.96
- Technical
- Relative Strength Index (RSI)
- IPHA 35.62
- FCCO 64.00
- Support Level
- IPHA $1.71
- FCCO $21.80
- Resistance Level
- IPHA $1.92
- FCCO $23.84
- Average True Range (ATR)
- IPHA 0.09
- FCCO 0.58
- MACD
- IPHA -0.01
- FCCO 0.18
- Stochastic Oscillator
- IPHA 20.97
- FCCO 96.73
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About FCCO First Community Corporation
First Community Corp is a bank holding company. Along with its subsidiaries, it provides various banking products and services for professionals and small and medium-sized businesses, including consumer and commercial banking, mortgage, brokerage and investment, online banking, and insurance services. The company offers checking, savings, money market, individual retirement, and certificates of deposit accounts, and its lending lines include consumer loans, real estate loans, home improvement loans, home loans, flex loans, construction loans, agricultural loans, and others. The company's reportable segments are; Commercial and Retail Banking, which derives maximum revenue; Mortgage Banking; Investment Advisory and Non-Deposit; and Corporate.